Endurance Technologies IPO Opens Key Details and Market Outlook
Vickers Top Insider Picks Signal Potential Confidence Amid Market Volatility
Stellantis Turnaround Plan Prediction Market Regulation Oura IPO Filing Morning Market Movers
Trump Seeks Supreme Court Intervention to Halt TikTok Ban
Michael Saylor Tokenization Could Create Free Market for Credit and Yield Challenging Traditional Banking
SpaceX Delays Starships 12th Test Flight Eyes Friday Launch as V3 Version Debuts
FSEA Q3 2024 Earnings Modest Profitability Achieved Amidst Challenging Environment
MSN Q1 2024 Earnings Loss Reported as Stock Surges Over 20
VIPS Q4 2025 Earnings EPS Surprise Lifts Sentiment Amid Modest Stock Pullback
NEOV Q1 2026 Earnings NarrowerThanExpected Loss Drives Positive Market Reaction
FENC Q1 2026 Earnings Narrow EPS Beat Highlights Cost Discipline Amid Revenue Discontinuity
TSS Inc TSSI Q1 2026 Earnings Stellar EPS Beat Drives Sharp Rally
GitLab Inc GTLB Surges 433 as Developer Platform Stock Eyes Key Resistance
Heartbeam Inc Warrant BEATW Rises 1077 as Tight Range Holds at 007
Interactive Strength Inc TRNR Plunges 15 Critical Support Tested After Steep Decline
Sypris Solutions SYPR Edges Higher as Stock Tests Key Technical Levels
Fulcrum Therapeutics FULC Steadies Near 657 as Biotech Sector Waits for Catalyst
Michael Saylor of Strategy Says Tokenization Could Enable Investors to Shop for Yield
Amdocs DOX Q1 2026 Earnings Slight EPS Miss Meets Modest Market Optimism
AXIA Energia AXIA Retreats from Resistance Support Levels Under Scrutiny
LQDA Q1 2026 Earnings EPS Surges Past Estimates Stock Edges Lower Amid Pipeline Updates
MGEE Q1 2026 Earnings Earnings Beat Bolsters Utilitys Steady Profile
Flanigans Enterprises Inc BDL Q3 2025 Earnings Positive EPS Delivers Share Boost Amid Sparse Disclosures
GSBC Q1 2026 Earnings EPS Surges 20 Above Estimates Amid Prudent Banking Operations
Hillman Solutions HLMN Q1 2026 Earnings EPS Falls Short Amid Challenging Environment
PLBC Q1 2026 Earnings EPS Beat of 712 Offsets Modest Share Price Decline
MGTX Q1 2026 Earnings Missed EPS Estimates as PreRevenue Biotech Advances Pipeline